Speaker Profile

Ph.D., CSO and Co-Founder, Alithea Bio UG

Tim Fugmann holds a PhD from ETH Zurich and has directed the target discovery efforts at the Philogen group (CH) before becoming Prof. for mass spectrometry-based proteomics in Germany. He co-founded Alithea Bio to facilitate and accelerate development of peptide HLA-targeted therapeutics such as TCR mimics and TCR T cell therapies. With Alithea his vision is to create a holistic view on the HLA-presented peptides to understand and guide immune reactions in individuals. For this, Alithea has created a large HLA peptide database from 3000 samples covering 1.1 Million ligands and their abundance in health and disease. Further, Alithea can readily identify novel targets and potential on and off-target toxicities. Alithea finally has a collection of HLA-typed healthy tissue samples in which epitopes of interest can be quantified down to few molecules per cell.


Clinical & Research Tools Showcase:
Alithea Bio UG

Alithea Bio focuses on HLA-presented peptides and facilitates highly sensitive detection and quantification for target discovery, validation and tox prediction. Alithea has a cloud-based HLA peptide database with >1.1 Million epitopes and their abundance in health and disease facilitating precision medicine applications

A holistic view on the HLA peptidome
Big data and highly sensitive MS technology facilitates detection and quantification of clinical HLA peptide targets

 Session Abstract – PMWC 2023 Silicon Valley

Showcase Track S2 - January 25 2.45 P.M.-4.00 P.M.,Showcase Track S2 - January 26 1.30 P.M.-4.00 P.M.,Showcase Track S2 - January 27 1.15 P.M.-1.30 P.M.

The PMWC 2023 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.


Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by APR. 25TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts

Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required